CXCR3和CXCR6对帕金森病患者循环T细胞的作用
Yufeng Zhang1,2,3, Zhuangzhuang Ren3,4,5, Shuangshuang Jia3,5,6
1Medical School of Chinese PLA, Beijing, China.
Scandinavian journal of immunology
|February 8, 2026
概括
帕金森病 (PD) 的免疫失调涉及T细胞. 这项研究发现PD患者T细胞上CXCR3和CXCR6的表达增加,这表明在疾病发病过程中发挥了作用,尽管与外周炎症没有明确的联系.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- T细胞生物学T细胞生物学
背景情况:
- 免疫失调与帕金森病 (PD) 病原发生有关.
- 在PD中,C-X-C基因化学受体3 (CXCR3) 和化学受体6 (CXCR6) 在T细胞上的特定作用及其与外周炎症的关联尚未得到充分了解.
研究的目的:
- 在帕金森病患者的外周血液T细胞上研究CXCR3和CXCR6的表达.
- 探索这些化学受体表达与PD外周炎症标志物之间的相关性.
主要方法:
- 采用多色流细胞测量方案分析T细胞表面标记物,包括CD3,CD4,CD8,CD45RO,CXCR3和CXCR6.
- 从36名PD患者和26名健康对照组中收集了临床信息和实验室测试结果 (SII,NLR,MLR,PLR,MHR,RPR,CRP).
主要成果:
- 与健康对照组相比,PD患者的CD8+T细胞显著减少.
- 在PD患者中,CXCR3表达在CD4+效应T细胞和CD8+T细胞上显著增加.
- 在PD患者的细胞毒性T淋巴细胞 (CTLs) 上,CXCR6表达显著升高,但在CD4+T细胞上没有. 患有PD的患者也显示CRP水平增加,单细胞,淋巴细胞和MHR减少.
结论:
- 对CXCR3和CXCR6的高调表达,特别是在CD8+T淋巴细胞上,可能有助于帕金森病的发病.
- 尽管观察到T细胞受体表达和炎症标志物的变化,但在这个PD队列中,CXCR3/CXCR6表达和外周炎症之间没有发现显著的相关性.
相关概念视频
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...